<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd" MadCap:lastBlockDepth="6" MadCap:lastHeight="660" MadCap:lastWidth="876" xmlns:MadCap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
    <head>
        <link href="../Resources/TableStyles/dnb_tablestyle_1.css" rel="stylesheet" MadCap:stylesheetType="table" />
    </head>
    <body>
        <h1>
   KYTHERA Biopharmaceuticals, Inc.
  </h1>
        <div style="display: none;">
            <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
                </col>
                <thead>
                    <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
                        <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
                        <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
                        <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
                    </tr>
                </thead>
                <tbody>
                    <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
                        <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
        800791118
      </td>
                        <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       162818
      </td>
                        <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       2
      </td>
                    </tr>
                </tbody>
            </table>
        </div>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" />
        <p>
   KYTHERA Biopharmaceuticals hopes to one day help patients want to take (its product) on the chin. A maker of pharmaceutical products&#160;for the aesthetics market, KYTHERA is developing an injectable drug used to reduce submental fat, which can cause what is colloquially known as a "double chin."&#160;The company&#160;is seeking to commercialize the drug, currently in clinical stage development,&#160;in the US and Canada. It also has trials underway in Europe through a licensing agreement with
   <company id="41808">
    Bayer
   </company>
   .&#160;Formed in&#160;2004, the company&#160;completed&#160;an IPO&#160;in 2012.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 IPO.flsnp" />
        <p>
   KYTHERA intends to use a significant portion of the proceeds raised in its IPO (about $81 million) to fund advanced-stage clinical trials for its drug.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Financial Performance.flsnp" />
        <p>
   Like many biopharmaceutical companies, KYTHERA spends heavily on research and development and has a history of operating losses. As of early 2012, the company had accumulated a deficit of $90.4 million. Its losses are partially offset by revenue it generates from its licensing agreement with Bayer.
  </p>
        <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" />
    </body>
</html>